02-Mar-2007 - A highly-acquisitive and research-intensive year has left drug discovery services provider Galapagos further in the red at the end of its 2006 financial year, although sales soared.
01-Mar-2007 - Lonza, Athersys, TyRx Pharma, JFC and Precision Pharma Services have all announced new contract manufacturing deals this week.
28-Feb-2007 - Multisorb Technologies has introduced a new advanced simulation service to help pharmaceutical companies determine the precise amount of sorbent needed in their packaging to protect products from moisture and degradation.
28-Feb-2007 - Drug development services provider Aptuit has announced it is about to invest $100m to expand its operations, just a few weeks after completing two major acquisitions.
28-Feb-2007 - The biopharmaceutical contract manufacturing sector is set to expand substantially in the next few years as biotech companies increasingly rely on outsourcing to improve efficiency and reduce costs, new research suggests.
28-Feb-2007 - UK firms Melbourn Scientific and Copley Scientific have agreed to collaborate on developing novel methods of testing the force of nasal sprays and metered-dose inhalers (MDIs).
27-Feb-2007 - Nicholas Piramal has announced it will spend $50m (€38m) on its formulations services business over the next three years, part of which will be used to fund its planned assault on the US.
27-Feb-2007 - Shire Pharmaceuticals' plans to buy New River Pharmaceuticals will eventually affect a contract manufacturing arrangement with Albany Molecular Research (AMR).
26-Feb-2007 - Using contractors to fulfil packaging needs can significantly reduce the time new products take to hit the market, claimed Gareth Lewis of Cardinal Health, speaking at SMi's Pharmaceutical Packaging and Labelling conference in London last week.
22-Feb-2007 - After shedding two of its unwanted divisions, a leaner Cambrex has decided to channel its energy into its high potency development (HiPO) business.
21-Feb-2007 - Pharmaceutical services group Almac Sciences has teamed up with enzyme catalyst firm BioCatalytics on process development and manufacture of chiral intermediates and active pharmaceutical ingredients (APIs).
21-Feb-2007 - QSV, Novasep and Cytovance have all announced new contract manufacturing deals this week, while Hyaluron has unveiled its production plant expansion.
20-Feb-2007 - Global compliance is becoming a key differentiator for contract manufacturing organisations (CMOs) who want to stay ahead of the game in the buoyant but competitive active pharmaceutical ingredients (APIs) manufacturing market.
19-Feb-2007 - Excelsyn and SAFC Both announced improvements to their UK contract manufacturing operations at this year's pharma services and specialty chemicals trade show, InformexUSA, in San Francisco.
19-Feb-2007 - Northern Ireland-based Almac Services has recently been awarded a potent compound safety certification by SafeBridge, confirming that Almac is capable of handling potent compounds safely and is able to limit exposure using closed laboratory systems.
15-Feb-2007 - Invitrogen has decided to sell BioReliance, the 'beleaguered' pharmaceutical services arm of its business, for less than half the price they paid for it just three years ago.
14-Feb-2007 - UK contract research organisation (CRO) Geneservice has announced its acquisition of the DNA sequencing facility in the University of Oxford's Biochemistry Department.
14-Feb-2007 - Biotech contract manufacturer Diosynth and PDL Biopharma have extended their agreement for the commercial supply of PDL's heart attack treatment Retavase (reteplase), a move that signals the end of manufacturing issues PDL experienced with the drug.
14-Feb-2007 - Albany Molecular Research (AMRI) has slipped again in the fourth quarter of 2006 recording an operating loss of $2.5m (€1.9m) - six per cent worse than the same quarter the previous year - despite encouraging revenue growth in its contract business.
13-Feb-2007 - A new partnership between India's Reliance Life Sciences (RLS) and Ireland's GeneMedix will provide new contract opportunities for European contract bio-manufacturers.
12-Feb-2007 - A new start up company in the UK has been formed with ambitions to shape itself into a global early-phase drug development services group through an acquisition-based strategy.
07-Feb-2007 - Contract manufacturer Lonza has completed its acquisition of two Cambrex subsidiaries, research bioproducts and microbial biopharmaceutical, in a move that is fuelled by its strategic move into biopharmaceuticals.
07-Feb-2007 - US-based Averion has signed a deal with an Indian contract research organisation (CRO) to offer combined services to pharma and biotech companies.
06-Feb-2007 - MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food and Drug Administration (FDA).
05-Feb-2007 - A UK-based firm is offering advice to chemical and pharmaceutical companies on reducing hazardous waste and adhering to the Registration, Evaluation and Authorisation of Chemicals Regulation (REACH), which becomes law on 1 June 2007.